Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril–Valsartan in Clinical Trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril–Valsartan in Clinical Trials

Published:2022-09 Issue:5 Volume:29 Page:e572-e575
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Cordero Alberto,Nuñez Julio,Bertomeu-González Vicente,Fácila Lorenzo,Quintanilla Mª Amparo,Rodríguez-Mañero Moisés,Escribano David,Valle Alfonso,de la Espriella Rafael,Torres-Llergo Javier,Bayés-Genís Antoni,González-Juanatey José R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference11 articles.

1. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC;McDonagh;Eur Heart J.,2021

2. Angiotensin-neprilysin inhibition versus enalapril in heart failure;McMurray;N Engl J Med.,2014

3. Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction;Solomon;N Engl J Med.,2019

4. Angiotensin receptor–neprilysin inhibition in acute myocardial infarction;Pfeffer;N Engl J Med.,2021

5. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials;Sterne;BMJ,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP